tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Gobind Singh, 16 are a BUY (94.12%), 1 are a HOLD (5.88%).
Analyst Gobind Singh, currently employed at HC WAINWRIGHT, carries an average stock price target met ratio of 50% that have a potential upside of 36.05% achieved within 222 days.
Gobind Singh’s has documented 34 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RPHM, Reneo Pharmaceuticals at 08-Sep-2023.
Analyst best performing recommendations are on RPHM (RENEO PHARMACEUTICALS).
The best stock recommendation documented was for RPHM (RENEO PHARMACEUTICALS) at 9/19/2022. The price target of $31 was fulfilled within 8 days with a profit of $9.8 (24.02%) receiving and performance score of 30.02.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$2
$1.95 (3900.00%)
$80
2 years 6 months 20 days ago
(26-Jul-2023)
1/2 (50%)
$-5.88 (-74.62%)
83
Buy
$10
$9.96 (24900.00%)
$10
2 years 10 months 29 days ago
(17-Mar-2023)
2/2 (100%)
$4.82 (93.05%)
79
Buy
$5
$4.96 (12400.00%)
2 years 10 months 30 days ago
(16-Mar-2023)
1/1 (100%)
$-0.98 (-16.39%)
4
Buy
$280
3 years 14 days ago
(01-Feb-2023)
1/3 (33.33%)
$120.6 (75.66%)
6
Buy
$50
$49.95 (99900.00%)
$12
3 years 2 months 30 days ago
(16-Nov-2022)
3/4 (75%)
$4.2 (9.17%)
100
What Year was the first public recommendation made by Gobind Singh?
